MIRA INFORM REPORT

 

 

Report Date :

10.11.2012

 

IDENTIFICATION DETAILS

 

Name :

ESCO MICRO PTE LTD

 

 

 

 

Formerly Known as:

CAPRI MARKETING SERVICES PTE LTD (14/06/1994)

 

 

Registered Office :

 

21 Changi South Street 1, 486777

 

 

 

 

Country :

Singapore.

 

 

 

 

Date of Incorporation :

12.01.1984

 

 

 

 

Com. Reg. No.:

198400165-W

 

 

 

 

Legal Form :

Exempt Private

 

 

 

 

Line of Business :

Dealing And Servicing of Clean Air, Containment and Laboratory Equipment, Fume Filtration and Biotechnology Equipment

 

 

 

 

No. of Employees :

80

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Singapore

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SINGAPORE - ECONOMIC OVERVIEW

 

Singapore has a highly developed and successful free-market economy. It enjoys a remarkably open and corruption-free environment, stable prices, and a per capita GDP higher than that of most developed countries. The economy depends heavily on exports, particularly in consumer electronics, information technology products, pharmaceuticals, and on a growing financial services sector. Real GDP growth averaged 8.6% between 2004 and 2007. The economy contracted 1.0% in 2009 as a result of the global financial crisis, but rebounded 14.8% in 2010 and 4.9% in 2011, on the strength of renewed exports. Over the longer term, the government hopes to establish a new growth path that focuses on raising productivity, which has sunk to a compound annual growth rate of just 1.8% in the last decade. Singapore has attracted major investments in pharmaceuticals and medical technology production and will continue efforts to establish Singapore as Southeast Asia's financial and high-tech hub.

Source : CIA

EXECUTIVE SUMMARY

 

 

REGISTRATION NO.

:

198400165-W

COMPANY NAME

:

ESCO MICRO PTE LTD

FORMER NAME

:

CAPRI MARKETING SERVICES PTE LTD (14/06/1994)

INCORPORATION DATE

:

12/01/1984

COMPANY STATUS

:

EXIST

LEGAL FORM

:

EXEMPT PRIVATE

LISTED STATUS

:

NO

REGISTERED ADDRESS

:

21 CHANGI SOUTH STREET 1, 486777, SINGAPORE.

BUSINESS ADDRESS

:

21, CHANGI SOUTH STREET 1, 486777, SINGAPORE.

TEL.NO.

:

65-65420833

FAX.NO.

:

65-65426920

EMAIL

:

mail@escoglobal.com

WEB SITE

:

www.escoglobal.com

CONTACT PERSON

:

LIM LAY YEW ( DIRECTOR )

PRINCIPAL ACTIVITY

:

DEALING AND SERVICING OF CLEAN AIR, CONTAINMENT AND LABORATORY EQUIPMENT, FUME FILTRATION AND BIOTECHNOLOGY EQUIPMENT

AUTHORISED CAPITAL

:

6,505,035.00 ORDINARY SHARE, OF A VALUE OF SGD 6,515,075.00

ISSUED AND PAID UP CAPITAL

:

6,505,035.00 ORDINARY SHARE, OF A VALUE OF SGD 6,515,075.00

SALES

:

N/A

NET WORTH

:

N/A

STAFF STRENGTH

:

80 [2012]

BANKER (S)

:

OVERSEAS UNION BANK LTD
STANDARD CHARTERED BANK
UNITED OVERSEAS BANK LIMITED

LITIGATION

:

TRACED

FINANCIAL CONDITION

:

N/A

PAYMENT

:

N/A

MANAGEMENT CAPABILITY

:

AVERAGE

 

 

 

COMMERCIAL RISK

:

MODERATE

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

SATISFACTORY

INDUSTRY OUTLOOK

:

AVERAGE GROWTH

 

 

 

HISTORY / BACKGROUND

 

The SC is an exempt private company which is allowed to have a minimum of two and a maximum of twenty shareholders and all the shareholders must be individuals. An exempt company is a type of private limited company. As a private limited company, the SC must have at least two directors. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the SC is capable of owning assets, entering into contracts, suing or be sued by other companies. The SC is governed by the Companies Act and must file in its annual return. The SC need not file in its financial statements but it has to file in a document duly signed by its director in charge of its finance, the secretary and its auditor stating that the SC is able to meet all its obligations as and when they fall due. Although the SC is not required to file in its financial statements, it also has to prepare its financial account which must be presented at the Annual General Meeting.

The SC is principally engaged in the (as a / as an) dealing and servicing of clean air, containment and laboratory equipment, fume filtration and biotechnology equipment.

 

The major shareholder(s) of the SC are shown as follows :

 

Name

Address

IC/PP/Loc No

Shareholding

(%)

LOW YAE FOONG +

26 SENNETT TERRACE, 466721, SINGAPORE.

S2554224Z

2,602,014.00

40.00

LIN XIANG QIAN +

29 AMBER ROAD, 15-03, SEA VIEW, 439942, SINGAPORE.

S8404232C

2,602,014.00

40.00

LIM LAY YEW +

26 SENNETT TERRACE, SENNETT VILLE, 466721, SINGAPORE.

S0005859I

1,301,007.00

20.00

 

 

 

---------------

------

 

 

 

6,505,035.00

100.00

 

 

 

============

=====

 

+ Also Director

 

 

DIRECTORS

 

DIRECTOR 1

 

Name Of Subject

:

LIM LAY YEW

Address

:

26 SENNETT TERRACE, SENNETT VILLE, 466721, SINGAPORE.

IC / PP No

:

S0005859I

Nationality

:

SINGAPOREAN

Date of Appointment

:

24/01/1984

 

 

 

 

DIRECTOR 2

 

Name Of Subject

:

LOW YAE FOONG

Address

:

26 SENNETT TERRACE, 466721, SINGAPORE.

IC / PP No

:

S2554224Z

Nationality

:

SINGAPOREAN

Date of Appointment

:

24/01/1984

 

DIRECTOR 3

 

Name Of Subject

:

LIN XIANG QIAN

Address

:

29 AMBER ROAD, 15-03, SEA VIEW, 439942, SINGAPORE.

IC / PP No

:

S8404232C

Nationality

:

SINGAPOREAN

Date of Appointment

:

22/03/2011

 

 

 

 

 

MANAGEMENT

 

 

 

1)

Name of Subject

:

LIM LAY YEW

 

Position

:

DIRECTOR

 

 

 

AUDITOR

 

Auditor

:

RELIANCE AUDIT LLP

Auditor' Address

:

N/A

 

 

 

COMPANY SECRETARIES

 

1)

Company Secretary

:

CHAN LAI YIN

 

IC / PP No

:

1296164B

 

Address

:

349 WOODLANDS AVENUE 3, 13-51, 730349, SINGAPORE.

 

 

 

 

 

 

 

BANKING


Banking relations are maintained principally with :

1)

Name

:

OVERSEAS UNION BANK LTD

 

2)

Name

:

STANDARD CHARTERED BANK

 

3)

Name

:

UNITED OVERSEAS BANK LIMITED

 

The SC enjoys normal banking routine with above mentioned banker(s). The SC has bank charges with above mentioned banker(s).

 

 

ENCUMBRANCE (S)


ENCUMBRANCE 1

Description Of Charge

:

ALL MONIES OWING

 

Amount Secured

:

N/A

Description Of Property Affected

:

N/A

 

Name & Address Of Chargee

:

OVERSEAS UNION BANK LTD

 

 

 

 

 

 

 

 

Form 40 Dated 08/08/1997

Registered and Numbered 199704828 In The Register of Charges


ENCUMBRANCE 2

Date of Creation

:

07/10/2009

Description Of Charge

:

N/A

 

Amount Secured

:

N/A

Description Of Property Affected

:

N/A

 

Name & Address Of Chargee

:

STANDARD CHARTERED BANK

 

 

 

 

 

Form 40 Dated

Registered and Numbered C200906374 In The Register of Charges


ENCUMBRANCE 3

Date of Creation

:

17/07/2012

Description Of Charge

:

N/A

 

Amount Secured

:

N/A

Description Of Property Affected

:

N/A

 

Name & Address Of Chargee

:

UNITED OVERSEAS BANK LIMITED

 

 

Form 40 Dated

Registered and Numbered C201207950 In The Register of Charges



LEGAL CHECK AGAINST SC


* A check has been conducted in our databank against the SC whether the subject has been involved in any litigation.

LEGAL ACTION

 

 

 

Code No

:

99

Case No

:

MC6886/2008

Year

:

2008

Place

:

SINGAPORE

Court

:

MAGISTRATE COURT

 

 

 

Date Filed

:

20/03/2008

 

 

 

Plaintiff

:

KOH TING KIN

Defendants

:

ESCO MICRO PTE LTD (198400165)

21 CHANGI SOUTH STREET 1, 486777, SINGAPORE.

 

Amount Claimed

:

5,940.00

 

 

 

Nature of Claim

:

SGD

 

 

 

Remark

:

NEGLIGENCE

Code No

:

99

Case No

:

MC19835/2008

Year

:

2008

Place

:

SINGAPORE

Court

:

MAGISTRATE COURT

 

 

 

Date Filed

:

07/08/2008

 

 

 

Plaintiff

:

LIM BOON CHUAN

Defendants

:

ESCO MICRO PTE LTD (198400165)

21 CHANGI SOUTH STREET 1, 486777, SINGAPORE.

 

Amount Claimed

:

1,532.00

 

 

 

 

Nature of Claim

:

SGD

 

 

 

 

Remark

:

NEGLIGENCE

 

NOTE:

Please check with creditors for confirmation as alleged debts may have been paid since recorded or are being disputed. The person wo has been sued has the same name as the subject. However, we are unable to determine whether the person sued is the one and the same person.

 

No winding up petition was found in our databank

 

 

 

PAYMENT RECORD

 

 

SOURCES OF RAW MATERIALS:

Local

:

YES

Overseas

:

YES



CLIENTELE

 

Local

:

YES

 

Domestic Markets

:

SINGAPORE

 

Overseas

:

YES

 

Export Market

:

WORLDWIDE

 

Credit Term

:

AS AGREED

 

Payment Mode

:

CHEQUES,TELEGRAPHIC TRANSFER (TT)

 

 

 

 

 

 

 


SOME OF SC'S CLIENTS:
* PFIZER ITALIA SRL, ITALY
* SIGMA-TAU PHARMACEUTICALS, ITALY
* KATHOLEIKE UNIVERSITEIT LEUVEN, BELGIUM
* KTL (NATIONAL PUBLIC HEALTH INSTITUTE), HELSINKI, FINLAND
* HISTORX, INC., CT, USA
* US DEPARTMENT OF AGRICULTURE, USA
* NASA LANGLEY RESEARCH CENTRE, USA
* CENTRAL FLORIDA REGIONAL HOSPITAL, USA
* BOEING COMPANY, USA
* UNILEVER FOOD RESEARCH CENTRE, NETHERLANDS
* MINISTRY OF HEALTH, POLAND
* MEDICAL RESEARCH COUNCIL, LONDON, UK
* GLAXO-WELLCOME OPERATIONS, UK
* MONASH UNIVERSITY, AUSTRALIA
* ROYAL MELBOURNE HOSPITAL, AUSTRALIA
* HOSPITAL SANTA FE, MEXICO
* MINISTRY OF HEALTH, KUWAIT
* MAGRABI HOSPITALS, SAUDI ARABIA
* TATA INSTITUTE OF FUNDAMENTAL RESEARCH, INDIA
* BIOCON BIOPHARMACEUTICAL PVT LTD, INDIA
* PROJECT DIRECTORY ON POULTRY (ICAR) INDIA
* CENTRAL TUBERCULOSIS RESEARCH INSTITUTE, MOSCOW, RUSSIA
* NIHON PHARMACEUTICAL INDUSTRY, CO., LTD, JAPAN
* KYOTO PHARMACEUTICAL UNIVERSITY, JAPAN
* SAN MIGUEL BREWERY, PHILIPPINES
* MAKATI MEDICAL CENTRE, PHILIPPINES
* SILPAKORN UNIVERSITY, THAILAND
* SHANGHAI UNIVERSITY, CHINA
* CHINA CDC, BEIJING, CHINA
* WORLD HEALTH ORGANIZATION

 

 

OPERATIONS

 

Goods Traded

:

CLEAN AIR, CONTAINMENT AND LABORATORY EQUIPMENT, FUME FILTRATION AND BIOTECHNOLOGY EQUIPMENT

 

Award

:

1 ) ISO 14001 Year :0
2 ) ISO 9001 Year :0

 

 

 

Total Number of Employees:

YEAR

2012

 

GROUP

N/A

 

COMPANY

80

 

 

Branch

:

NO

 

 

Other Information:


The SC is principally engaged in the (as a / as an) dealing and servicing of clean air, containment and laboratory equipment, fume filtration and biotechnology equipment.

The SC is a company focused on clean air and containment equipment technology. It is highly oriented towards the international marketplace with distribution in more than 70 countries - and a direct presence in 10 of the key global markets

The SC involved in the following activities:

* Dealing of clean air, containment and laboratory equipment, fume filtration and biotechnology equipment

* Supply of complete range of clean room related products and supplies

* Static elimination/ESD equipment & products, clean room apparel, complete range of filters (hepa/ashrae/viledon filters) and water purification systems.

* Supply and installation of laminar flow devices, biohazard cabinets, air-shower and pass boxes

* Certification/calibration services for clean rooms/laminar flow devices/biohazard cabinets/fume cupboards/ESD equipment.

* Complete range of services from evaluation to assessment to rectification of indoor air quality problem/sick building syndrome

Products:

* Laboratory Equipment

* Cleanroom Construction Components

* Cleanroom Equipment & Supplies

* Cleanroom Apparel

* Cleanroom Filters

* Horizontal Laminar Flow Cabinets

* Vertical Laminar Flow Cabinets

* Class Ii Safety Cabinets

* Class Iii Safety Cabinets

* Cytotoxic Cabinets

* Pcr Cabinets

* Animal Handling Cabinets

* Ivf Cabinets

* Weighing Cabinets

* Ergonomic Accessories

* Accessories

Trade names:

* Esco Labculture

Industries served:

* Biotechnology

* Life Sciences

* Pharmaceuticals

* Education

* Clinical

The SC is a member of following entities:

* The Pharmaceutical Society of Singapore

* Singapore Manufacturers' Federation

* Asia-Pacific Biosafety Association

* Institute of Environmental Sciences and Technology (IEST)

* American Biological Safety Association (ABSA)

* Laboratory Products Association (LPA).


CURRENT INVESTIGATION

 

Latest fresh investigations carried out on the SC indicated that :

Telephone Number Provided By Client

:

N/A

Current Telephone Number

:

65-65420833

Match

:

N/A

 

 

 

Address Provided by Client

:

21, CHANGI SOUTH STREET 1,486777

Current Address

:

21, CHANGI SOUTH STREET 1, 486777, SINGAPORE.

Match

:

YES

 

 

 

 

Other Investigations


On 7th November 2012 we contacted one of the staff from the Admin Department. She provided some information on the SC.

 

FINANCIAL ANALYSIS

 

 

The SC is a private exempt company which does not need to file in its accounts with the Registrar of Companies for the information of the public. Therefore, we are not able to comment on the SC's financial performance.

 

 

 

 

 

 

 

Overall financial condition of the SC : N/A

 

 

SINGAPORE ECONOMIC / INDUSTRY OUTLOOK

 

 

Major Economic Indicators :

2006

2007

2008

2009

2010

 

 

 

 

 

 

Population (Million)

4.40

4.58

4.84

4.98

5.08

Gross Domestic Products ( % )

8.7

8.8

1.5

<0.8>

14.5

Consumer Price Index

1.0

2.1

6.6

0.6

2.8

Total Imports (Million)

378,924.1

395,979.7

450,892.6

356,299.3

423,221.8

Total Exports (Million)

431,559.2

450,627.7

476,762.2

391,118.1

478,840.7

 

 

 

 

 

 

Unemployment Rate (%)

2.7

2.3

2.2

3.2

2.2

Tourist Arrival (Million)

9.75

10.28

10.12

9.68

11.64

Hotel Occupancy Rate (%)

85.2

87.0

81.0

75.8

85.6

Cellular Phone Subscriber (Million)

1.05

1.22

1.31

1.37

1.43

 

 

 

 

 

 

Registration of New Companies (No.)

21,495

25,903

25,327

26,414

29,798

Registration of New Companies (%)

10.2

20.5

<2.2>

4.3

12.8

Liquidation of Companies (No.)

8,980

9,226

10,493

22,393

15,126

Liquidation of Companies (%)

28.1

2.7

13.7

113.4

<32.5>

 

 

 

 

 

 

Registration of New Businesses (No.)

24,219

24,762

24,850

26,876

23,978

Registration of New Businesses (%)

3.17

2.24

0.36

8.15

<10.78>

Liquidation of Businesses (No.)

26,843

21,322

21,150

23,552

24,211

Liquidation of Businesses (%)

<52.3>

<20.6>

<0.8>

11.4

2.8

 

 

 

 

 

 

Bankruptcy Orders (No.)

2,983

2,767

2,326

2,058

1,537

Bankruptcy Orders (%)

15.8

<7.2>

<15.9>

<11.5>

<25.3>

Bankruptcy Discharges (No.)

1,634

1,626

1,500

3,056

2,252

Bankruptcy Discharges (%)

<2.9>

<0.5>

<7.7>

103.7

<26.3>

 

 

 

 

 

 

INDUSTRIES ( % of Growth ) :

 

 

 

 

 

Agriculture

 

 

 

 

 

Production of Principal Crops

3.91

5.26

<0.32>

3.25

<0.48>

Fish Supply & Wholesale

1.33

<3.91>

<6.31>

<1.93>

3.60

 

 

 

 

 

 

Manufacturing *

94.4

100.0

95.8

91.8

119.1

Food, Beverages & Tobacco

89.9

100.0

107.7

102.7

109.5

Textiles

119.9

100.0

92.6

75.0

62.8

Wearing Apparel

114.5

100.0

71.8

45.3

26.4

Leather Products & Footwear

100.3

100.0

84.7

52.6

54.1

Wood & Wood Products

107.1

100.0

88.8

68.3

70.0

Paper & Paper Products

92.5

100.0

98.8

93.3

103.7

Printing & Media

97.6

100.0

96.7

82.5

84.7

Crude Oil Refineries

100.2

100.0

101.0

86.1

85.4

Chemical & Chemical Products

93.8

100.0

95.1

90.4

109.9

Pharmaceutical Products

102.1

100.0

92.8

104.4

159.9

Rubber & Plastic Products

100.1

100.0

92.2

77.6

86.1

Non-metallic Mineral

113.1

100.0

83.1

79.1

79.7

Basic Metals

110.0

100.0

120.9

101.9

112.5

Fabricated Metal Products

97.8

100.0

95.0

85.2

97.2

Machinery & Equipment

83.9

100.0

97.4

85.8

117.7

Electrical Machinery

98.8

100.0

98.1

104.2

149.1

Electronic Components

96.1

100.0

93.0

85.1

115.5

Transport Equipment

85.3

100.0

106.7

100.2

99.3

 

 

 

 

 

 

Construction

46.60

45.60

45.90

<36.9>

14.20

Real Estate

12.9

40.8

<11.2>

1.4

21.3

 

 

 

 

 

 

Services

 

 

 

 

 

Electricity, Gas & Water

<5.3>

11.00

<1.3>

1.70

4.00

Transport, Storage & Communication

6.00

8.50

11.60

3.90

12.80

Finance & Insurance

6.40

41.50

<5.9>

<16.4>

<0.4>

Government Services

13.50

3.80

17.40

4.50

9.70

Education Services

1.10

1.80

0.50

0.10

<0.9>

 

 

 

 

 

 

* Based on Index of Industrial Production (2007 = 100)

 

 

 

 

 

(Source : Department of Statistics)

 

 

 

 

 



INDUSTRY ANALYSIS

 

INDUSTRY :

TRADING


The 1st Quarter 2012 total retail sales is expected to grow from a forecast SGD44.45bn (US$35.28bn) in 2011 to SGD51.50bn (US$46.82bn) by 2015. Singapore lacks the advantage of a massive consumer base, its low unemployment rate, the rapid influx of foreign immigrants and increasing visitor arrivals will continue to instill dynamism into the local retail scene and further buoy consumer spending.


The February 2011 budget provided a boost to consumer spending power, with the SGD6.6bn (US$5.2bn) Total Benefits package earmarked for households in 2011-2012 expected to have positive implications for the Singapore consumer.


In terms of retail sub-sectors, the over-the-counter pharmaceutical sector to be worth US$0.15bn in 2011 and for sales to increase by more than 35% to US$0.20bn by 2015. Sales of consumer electronics products are expected to increase by nearly 24%, from US$3.96bn in 2011 to US$4.90bn by the end of the forecast period on the back of strong demand for high-end products such as multimedia notebooks, 3G phones and smartphones.


The food retail segment will have a market share of 21.3% in 2011, when the sub-sector is forecast to be worth US$7.50bn. Sales are expected to grow to US$8.11bn by 2015.


Mass grocery retail sales are forecast to be US$3.46bn in 2011 and to grow by more than 25% to US$4.45bn by 2015, more than three times the rate of growth for overall food sales. This would take mass grocery retail's share of the overall food market from 45.7% in 2011 to 52.9% by the end of the forecast period.


Retail sales of Asian countries in 2011 are forecast US$3.13trn. China and India are predicted to account for nearly 91% of regional retail sales in 2011, and by 2015 their share of the regional market is expected to be more than 92%. Growth in regional retail sales for 2011-2015 is forecast at 71.6%, an annual average 14.4%. India should experience the most rapid rate of growth, followed by China. Singapore's market share of 1.1% in 2011 is forecast to fall to 0.8% by 2015.

 

 

OVERALL INDUSTRY OUTLOOK : AVERAGE GROWTH



CREDIT RISK EVALUATION & RECOMMENDATION

 

 


Incorporated in 1984, the SC is an Exempt Private company, focusing on dealing and servicing of clean air, containment and laboratory equipment, fume filtration and biotechnology equipment. With its long presence in the industry coupled with its vast experiences in the business, the SC should have built up certain goodwill with its clients over times. The capital standing of the SC is fair. With an adequate share capital, the SC has the potential of expanding its business in future.


Over the years, the SC has penetrated into both the local and overseas market. The SC has positioned itself in the global market and is competing in the industry. Its stable clientele base will enable the SC to further enhance its business in the near term. Being a moderate size company, the SC has a total workforce of 80 employees in its business operations. Overall, we regard that the SC's management capability is average. This indicates that the SC has greater potential to improve its business performance and raising income for the SC.


As the SC is registered as an Exempt Private company, it is not required to file financial statements for public review. As such, we are unable to ascertain its present financial health.


The SC's supplier are from both the local and overseas countries. This will eliminates the risk of dependency on deliveries from a number of key suppliers and insufficient quantities of its raw materials. Overall the SC has a good control over its resources.


The industry shows an upward trend and this trend is very likely to sustain in the near terms. Hence, the SC is expected to benefit from the favourable outlook of the industry. The SC however faces moderate business risk as it has to compete with many well established players in the same field.


In view of the above, we recommend credit be granted to the SC with close monitoring.

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.54.34

UK Pound

1

Rs.86.97

Euro

1

Rs.69.43

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.